Skip to main content
Search
Search
Advanced Search
Skip main navigation
Free access
Short Communication
18 November 2021

Impact analysis of expanding narrow-spectrum antibiotic use for children with ear, sinus and throat infections

Authors: Carolina Barbosa https://orcid.org/0000-0002-7535-9443, Andrew Breck https://orcid.org/0000-0003-0950-5796 [email protected], Grant King, Sarah Bass, Yoojin Kook https://orcid.org/0000-0002-5079-5804, Amanda Honeycutt, and Dominick EspositoAuthor Info & Affiliations
Volume 11, Number 2
https://doi.org/10.2217/cer-2021-0064
PDFFormats

Abstract

Aim: Estimate the impacts treating acute respiratory tract infections (ARTIs) in children aged 6 months through 12 years with narrow-spectrum antibiotics. Materials & methods: Decision-tree model to estimate children’s health, healthcare utilization and costs, and caregiver’s time and costs for using narrow-spectrum antibiotics in eligible children with an ARTI, compared with current use of narrow- and broad-spectrum antibiotics. Results: Reduced adverse drug reactions by 35,750 (14%) cases) and 4750 (12%) fewer emergency department visits, 300 (12%) fewer hospitalizations, and 50,500 (10%) avoided outpatient visits. Annual healthcare costs fell by US$120 million (22%). Total societal costs declined by US$131 million (20%). Conclusion: National implementation of narrow-spectrum antibiotics to treat ARTIs in children improves patient outcomes and reduces caregiver burden and annual healthcare costs.

Supplementary Material

File (cer-2021-0064 supplementary materials.docx)

References

1.
American Academy of Pediatrics. Pneumococcal infection. In: Report of the Committee on Infectious Diseases. Pickering L, Baker C, Kimberlin D, Long S (Eds). American Academy of Pediatrics, IL, USA, 571–581 (2012).
Google Scholar
2.
Chow A, Benninger M, Brook I et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin. Infect. Dis. 54(8), e72–e112 (2012).
PubMed
Google Scholar
3.
Lovegrove MC, Geller AI, Fleming-Dutra KE, Shehab N, Sapiano MRP, Budnitz DS. US Emergency Department visits for adverse drug events from antibiotics in children, 2011–2015. J. Pediatric Infect. Dis. Soc. 8(5), 384–391 (2019).
PubMed
Google Scholar
4.
Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013–2014. J. Am. Med. Assoc. 316(20), 2115–2125 (2016).
Google Scholar
5.
Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect. Dis. 14(1), 1–25 (2014).
PubMed
Google Scholar
6.
Sarpong EM, Miller GE. Narrow- and broad-spectrum antibiotic use among U.S. children. Health Serv. Res. 50(3), 830–846 (2015).
PubMed
Google Scholar
7.
Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 128(6), 1053–1061 (2011).
PubMed
Google Scholar
8.
Gerber JS, Ross RK, Bryan M et al. Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections. J. Am. Med. Assoc. 318(23), 2325–2336 (2017).
Google Scholar
9.
Kawai K, Adil EA, Barrett D, Manganella J, Kenna MA. Ambulatory visits for otitis media before and after the introduction of pneumococcal conjugate vaccination. J. Pediatr. 201, 122–127.e1 (2018).
PubMed
Google Scholar
10.
Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics 127(1), 28–34 (2011).
PubMed
Google Scholar
11.
Dooling KL, Shapiro DJ, Van Beneden C, Hersh AL, Hicks LA. Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997–2010. JAMA Pediatr. 168(11), 1073–1074 (2014).
PubMed
Google Scholar
12.
Suaya JA, Gessner BD, Fung S et al. Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011–2016. Vaccine 36(49), 7479–7486 (2018).
PubMed
Google Scholar
13.
Gidengil CA, Kruskal BA, Lee GM. Initial antibiotic choice in the treatment of group A streptococcal pharyngitis and return visit rates. J. Pediatric Infect. Dis. Soc. 2(4), 361–367 (2013).
PubMed
Google Scholar
14.
Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parent-reported penicillin allergy symptoms in the Pediatric Emergency Department. Acad. Pediatr. 17(3), 251–255 (2017).
PubMed
Google Scholar
15.
Kerr J. Penicillin allergy: a study of incidence as reported by patients. Br. J. Clin. Pract. 48(1), 5–7 (1994).
PubMed
Google Scholar
16.
Lee CE, Zembower TR, Fotis MA et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch. Intern. Med. 160(18), 2819–2822 (2000).
PubMed
Google Scholar
17.
Nicklas R, Bernstein I, Li J. β-Lactam antibiotics: the diagnosis and management of anaphylaxis. J. Allergy Clin. Immunol. 101(Suppl.), S498–S501 (1999).
Google Scholar
19.
Chahine EB, Johnson AN, Costanzo A. Update on the management of pediatric acute otitis media. US Pharm. 39(7), 27–30 (2014).
Google Scholar
20.
McMahon Wicker A, Labruzzo Mohundro B. Management of pediatric otitis media. US Pharm. 35(3), 44–49 (2010).
Google Scholar
21.
TOP (Toward Optimized Practice). Diagnosis and treatment of AOM in children: summary of the Alberta clinical practice guideline for acute otitis media (2008 Update).
Google Scholar
22.
DeMuri GP, Wald ER. Acute bacterial sinusitis in children. N. Engl. J. Med. 367(12), 1128–1134 (2012).
PubMed
Google Scholar
23.
Contopoulos-Ioannidis DG, Ioannidis JPA, Lau J. Acute sinusitis in children: current treatment strategies. Pediatr. Drugs 5(2), 71–80 (2003).
PubMed
Google Scholar
24.
Leung AKC, Kellner JD. Acute sinusitis in children: diagnosis and management. J. Pediatr. Heal. Care 18(2), 72–76 (2004).
PubMed
Google Scholar
25.
Shulman ST, Bisno AL, Clegg HW et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America [Published correction in Clinical Infectious Diseases (2014), 58(10), 1496]. Clin. Infect. Dis. 58(10), 1496 (2014).
Google Scholar
26.
Milatovic D, Adam D, Hamilton H, Materman E. Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. Antimicrob. Agents Chemother. 37(8), 1620–1623 (1993).
PubMed
Google Scholar
27.
Syrogiannopoulos GA, Bozdogan B, Grivea IN et al. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr. Infect. Dis. J. 23(9), 857–865 (2004).
PubMed
Google Scholar
28.
Tack KJ, Henry DC, Manford Gooch W et al. Five-day cefdinir treatment for streptococcal pharyngitis. Antimicrob. Agents Chemother. 42(5), 1073–1075 (1998).
PubMed
Google Scholar
29.
Chahine EB, Chamoun J, Sucher AJ. Management of streptococcal pharyngitis. US Pharm. 38(7), 51–56 (2013).
Google Scholar
30.
Choby BA. Diagnosis and treatment of streptococcal pharyngitis. Am. Fam. Physician 79(5), 383–390 (2009).
PubMed
Google Scholar
31.
U.S. Department of Labor Bureau of Labor Statistics. Civilian labor force participation rate, seasonally adjusted total for all months in 2018. News release chart (2018).
Google Scholar
32.
US Department of Labor Bureau of Labor Statistics. Current Population Survey: Unadjusted median usual weekly earnings, Employed full time, Wage and salary workers. BLS Data Viewer Series LEU0252881500 (2018).
Google Scholar
33.
U.S. Census Bureau. 2017 National Population Projections Datasets: Projections for the United States, 2017 to 2060 (2018) https://www.census.gov/data/datasets/2017/demo/popproj/2017-popproj.html
Google Scholar
34.
CDC (Centers for Disease Control and Prevention). Data Table of Infant Weight-for-age Charts. Growth Charts (2001) https://www.cdc.gov/growthcharts/html_charts/wtageinf.htm
Google Scholar
35.
AHRQ (Agency for Healthcare Research and Quality). MEPS: Medical Expenditure Panel Survey 2006–2015 data (2019) https://meps.ahrq.gov/data_stats/download_data_files.jsp
Google Scholar
36.
U.S. Bureau of Economic Analysis. Personal consumption expenditures: Services: Health care (chain-type price index). FRED. Federal Reserve Bank of St. Louis (2019). https://fred.stlouisfed.org/series/DHLCRG3Q086SBEA
Google Scholar
37.
Ray KN, Chari AV, Engberg J, Bertolet M, Mehrotra A. Opportunity costs of ambulatory medical care in the United States. Am. J. Manag. Care 21(8), 567–574 (2015).
PubMed
Google Scholar
38.
Schmier J, Ogden K, Nickman N et al. Costs of providing infusion therapy for rheumatoid arthritis in a hospital-based infusion center setting. Clin. Ther. 39(8), 1600–1617 (2017).
PubMed
Google Scholar
39.
U.S. Department of Labor Bureau of Labor Statistics. Employer costs for employee compensation for the regions – September 2019. News Release #19-19877-DAL (2019).
Google Scholar
40.
Hoberman A, Paradise JL, Rockette HE et al. Shortened antimicrobial treatment for acute Otitis media in young children. N. Engl. J. Med. 375(25), 2446–2456 (2016).
PubMed
Google Scholar
41.
Hoberman A, Paradise JL, Rockette HE et al. Treatment of acute otitis media in children under 2 years of age. N. Engl. J. Med. 364(2), 105–115 (2011).
PubMed
Google Scholar
|